Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children
- PMID: 26346028
- PMCID: PMC4540955
- DOI: 10.1155/2015/589471
Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children
Abstract
Objectives: Interferon-γ inducible protein 10 (IP-10), either in blood or in urine, has been proposed as a tuberculosis (TB) biomarker for adults. This study aims to evaluate the potential of IP-10 diagnostics in children from Uganda, a high TB-endemic country.
Methods: IP-10 was measured in the blood and urine concomitantly taken from children who were prospectively enrolled with suspected active TB, with or without HIV infection. Clinical/microbiological parameters and commercially available TB-immune assays (tuberculin skin test (TST) and QuantiFERON TB-Gold In-Tube (QFT-IT)) were concomitantly evaluated.
Results: One hundred twenty-eight children were prospectively enrolled. The analysis was performed on 111 children: 80 (72%) of them were HIV-uninfected and 31 (27.9%) were HIV-infected. Thirty-three healthy adult donors (HAD) were included as controls. The data showed that IP-10 is detectable in the urine and blood of children with active TB, independent of HIV status and age. However, although IP-10 levels were higher in active TB children compared to HAD, the accuracy of identifying "active TB" was low and similar to the TST and QFT-IT.
Conclusion: IP-10 levels are higher in children with respiratory illness compared to controls, independent of "TB status" suggesting that the evaluation of this parameter can be used as an inflammatory marker more than a TB test.
Figures



Similar articles
-
A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis.Pediatrics. 2014 Dec;134(6):e1568-75. doi: 10.1542/peds.2014-1570. Pediatrics. 2014. PMID: 25422019
-
Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection.Pediatr Infect Dis J. 2008 Dec;27(12):1073-7. doi: 10.1097/INF.0b013e31817d05a3. Pediatr Infect Dis J. 2008. PMID: 18946366
-
IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.J Infect. 2012 Jul;65(1):49-59. doi: 10.1016/j.jinf.2012.03.017. Epub 2012 Mar 29. J Infect. 2012. PMID: 22465752
-
Blood and urine inducible protein 10 as potential markers of disease activity.Int J Tuberc Lung Dis. 2016 Nov;20(11):1554-1561. doi: 10.5588/ijtld.16.0342. Int J Tuberc Lung Dis. 2016. PMID: 27776600
-
Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis.BMC Infect Dis. 2016 Mar 18;16:131. doi: 10.1186/s12879-016-1461-y. BMC Infect Dis. 2016. PMID: 26993789 Free PMC article.
Cited by
-
Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis.BMC Infect Dis. 2019 Oct 30;19(1):924. doi: 10.1186/s12879-019-4466-5. BMC Infect Dis. 2019. PMID: 31666025 Free PMC article.
-
Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.Am J Trop Med Hyg. 2016 Apr;94(4):728-35. doi: 10.4269/ajtmh.15-0633. Epub 2016 Feb 1. Am J Trop Med Hyg. 2016. PMID: 26834199 Free PMC article.
-
Tuberculosis Biomarkers: From Diagnosis to Protection.Infect Dis Rep. 2016 Jun 24;8(2):6568. doi: 10.4081/idr.2016.6568. eCollection 2016 Jun 24. Infect Dis Rep. 2016. PMID: 27403267 Free PMC article. Review.
-
Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis.EBioMedicine. 2018 May;31:157-165. doi: 10.1016/j.ebiom.2018.04.014. Epub 2018 Apr 22. EBioMedicine. 2018. PMID: 29752217 Free PMC article. Clinical Trial.
-
IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting.Sci Rep. 2019 Mar 7;9(1):3871. doi: 10.1038/s41598-019-40458-0. Sci Rep. 2019. PMID: 30846768 Free PMC article.
References
-
- WHO. Global tuberculosis report 2014. WHO Global TB Report 2014. 2014
-
- Portevin D., Moukambi F., Clowes P., et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. The Lancet Infectious Diseases. 2014;14(10):931–938. doi: 10.1016/s1473-3099(14)70884-9. - DOI - PubMed
-
- Cuevas L. E., Browning R., Bossuyt P., et al. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. The Journal of Infectious Diseases. 2012;205(supplement 2):S209–S215. doi: 10.1093/infdis/jir879. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources